Sort
50,496 grants matching “lung cancer”
Mechanistic Targeting of Lung Cancer
$728,236Lucy M Anderson · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Sex Hormones in Pulmonarv Arterial Hypertension
$728,233James E Loyd · Vanderbilt University · P01 · FY2012 · HL
Mechanistic Risk Prediction of Radiation Therapy Cardiotoxicity
$728,209Bonnie Ky · University Of Pennsylvania · R01 · FY2021 · HL
SHCC MU NCORP
$727,987Thomas Lad · Hektoen Institute For Medical Research · UG1 · FY2015 · CA
The Epidemiology of the Weiss Cohort Project
$727,891Stanley H Weiss · Rutgers Biomedical And Health Sciences · R01 · FY2025 · DA
Molecular Analysis Of Cell Cycle Control During Carcinogenesis
$727,845Richard S Paules · Environmental Health Sciences · Z01 · FY2007 · ES
Genetic Epidemiology of Lung Cancer
$727,821Ann G Schwartz · Wayne State University · R01 · FY2007 · CA
Development and Translation of Generator-Produced PET Tracer for Myocardial Perfusion Imaging
$727,792Vijay Sharma · Washington University · R01 · FY2020 · HL
Cellular, molecular and quantitative imaging analysis of screening-detected lung adenocarcinoma
$727,581Pierre P Massion · Vanderbilt University Medical Center · U01 · FY2017 · CA
A phase I/II combination immunotherapy clinical trial: mesothelin-targeted chimeric antigen receptor T cells and checkpoint blockade agent in pleural mesothelioma
$727,344Prasad S. Adusumilli · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA
A phase I/II combination immunotherapy clinical trial: mesothelin-targeted chimeric antigen receptor T cells and checkpoint blockade agent in pleural mesothelioma
$727,344Prasad S. Adusumilli · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA
Novel Nanovaccines Against Nicotine Addiction
$727,306Chenming M Zhang · Virginia Polytechnic Inst And St Univ · U01 · FY2014 · DA
Randomized Trial of Automated Video-Assisted Smoking Treatment for People Living with HIV
$727,274Damon J. Vidrine · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2021 · CA
ETIOLOGICAL PROCESSES IN THE ONSET AND MAINTENANCE OF ADVERSE HEALTH OUTCOMES IN MALTREATED YOUTH
$727,235Christine M Heim · Pennsylvania State University, The · P50 · FY2020 · HD
PARTNERSHIP FOR RESEARCH IN OPTICAL COHERENCE TOMOGRAPHY
$727,178Duke University · R24 · FY2002 · EB
Dissemination of the Cardiovascular Risk Service (CVRS Live)
$727,008Korey A Kennelty · University Of Iowa · R01 · FY2021 · HL
Radiation-induced translational control of gene expression
$726,840Philip Tofilon · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Targeting novel therapeutic vulnerabilities in LKB1 mutant tumors.
$726,766Nabeel Bardeesy · Massachusetts General Hospital · R01 · FY2018 · CA
T-cell subsets as CVD risk factors in CHS and MESA
$726,570Bruce M Psaty · University Of Washington · R01 · FY2014 · HL
Transformed Epithelial Cells and Activated Fibroblasts in the Esopheageal Tumor M
$726,557Anil K Rustgi · University Of Pennsylvania · P01 · FY2010 · CA
(3 of 3) MMC, VICC & TSU: Partners in Eliminating Cancer Disparities
$726,440Margaret M Whalen · Tennessee State University · U54 · FY2022 · CA
Common Pathogenetic Mechanisms of Lung Cancer and COPD
$726,338Chris H Wendt · University Of Minnesota · R01 · FY2012 · HL
NanoDisk-Amphotericin B therapy for aspergillosis
$726,199Trudy M Forte · Lypro Biosciences, Inc. · R44 · FY2010 · AI
Novel Quantitative Emphysema Subtypes in MESA and SPIROMICS
$725,923R Graham Barr · Columbia University Health Sciences · R01 · FY2020 · HL
The Thromboxane-Prostanoid Receptor in Radiation-Induced Pulmonary Fibrosis
$725,891James D West · Vanderbilt University Medical Center · R01 · FY2023 · CA